Investigators from the SWOG Cancer Research Network have developed and validated a risk prediction model for identifying ...

Herbal brain boosters are on the rise, but does science back them up? Here's some truth behind nootropics and their alleged ...

Cancer incidence trends in 2021 largely returned to what they were before the COVID-19 pandemic, according to a study by ...

Two researchers from the Icahn School of Medicine at Mount Sinai recently published their critical evaluation of a new brain ...

The "Thyroid Cancer - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest analytical report reveals a dynamic environment in the developmental landscape of ...

Anyone with any experience as an investor knows that while penny stocks can produce strong returns, they’re also risky. You ...

The "Vascular Dementia - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.A comprehensive analysis of the Vascular Dementia pipeline landscape set to transform the ...

US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects ...

Lead program TG4050 (individualized immunotherapy): – First signs of clinical benefit in adjuvant head and neck ... 2024 compared to €4.8 million for the same period in 2023. The research tax credit ...

Investigators from the SWOG Cancer Research Network have developed and validated a risk prediction model for identifying which patients with advanced cancer who are enrolled to clinical trials are at ...